Alpha 2.0
Login Register
» Articles » PMID: 38170900

Older Adults With Inflammatory Bowel Disease Are at Higher Risk of Developing Antibodies to Infliximab

Overview
Journal Inflamm Bowel Dis
Publisher Oxford University Press
Specialty Gastroenterology
Date 2024 Jan 3
PMID 38170900
Authors
Adam S Faye
Kate E Lee
David Hudesman
Thierry Dervieux
Affiliations
Soon will be listed here.
Citing Articles

Age as a Predictor of Serum Tumor Necrosis Factor Antagonist Drug and Antidrug Antibody Concentrations in Inflammatory Bowel Disease-A Nationwide Cohort Study.

Shehab M, Alrashed F J Clin Med. 2025; 14(4).

PMID: 40004589 PMC: 11856510. DOI: 10.3390/jcm14041057.

Inflammation and aging-related disease: A transdisciplinary inflammaging framework.

Andonian B, Hippensteel J, Abuabara K, Boyle E, Colbert J, Devinney M Geroscience. 2024; 47(1):515-542.

PMID: 39352664 PMC: 11872841. DOI: 10.1007/s11357-024-01364-0.

Optimal Management of Refractory Crohn's Disease: Current Landscape and Future Direction.

Lee K, Tu V, Faye A Clin Exp Gastroenterol. 2024; 17:75-86.

PMID: 38558912 PMC: 10981422. DOI: 10.2147/CEG.S359376.